Novozymes sees 2014 earnings in line with forecasts

Danish enzyme maker Novozymes said sales and operating profit for 2014 were roughly in line with analysts' expectations, but it trimmed its longer-term sales forecasts.

Revenue for 2014 came in at 12.46 billion Danish crowns ($1.94 billion) against a forecast for 12.48 billion in a Reuters poll. The company earned an operating profit of 3.38 billion crowns compared with 3.33 billion expected by analysts.

It said it saw annual organic sales growth of 8-10 percent through to 2020. That was a reduction from the 10 percent or more it had previously announced.

Follow us on Twitter: @CNBCWorld